Home » Topics » BioWorld Science, Patents

BioWorld Science, Patents
RSS

AstraZeneca patents novel agents for arrhythmia

June 28, 2012

Novel PI3K-alpha/mTORC1 inhibitors disclosed by Exelixis

June 28, 2012

New S1P1 receptor agonists prepared by Allergan

June 28, 2012

Novel S1P4 receptor ligands disclosed

June 27, 2012

Researchers at Esteve synthesize new agents for pain

June 27, 2012

Nissan Chemical Industry reports novel anticancer agents

June 27, 2012

New acetyl-CoA carboxylase inhibitors prepared in Japan

June 27, 2012

New levodopa prodrugs presented by Ono Pharmaceutical

June 27, 2012

Scientists at Exelixis design novel inhibitors of protein kinases

June 27, 2012

Allergan divulges new S1P1 receptor ligands

June 27, 2012

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 31, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 2, 2026.
AND-017 increases RBC and hemoglobin in sickle cell disease
BioWorld Science
Sickle cell disease (SCD) is an inherited hemoglobinopathy caused by a mutation in the gene encoding β-globin that results in hemoglobin S polymerization, red...
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...